Ordering
Available Variants25 mg
CHA.28816-25mg
Price
€75.68
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.28816-25mg | €75.68 |
≥98% (HPLC)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C35H52O5S2 |
|---|---|
| CAS Number | 216167-82-7 |
| Molecular Weight | 616.91 |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
| MDL number | MFCD08690469 |
| Assay | ≥98% (HPLC) |
| Form | powder |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
Technical Overview & Applications Use-case context
Succinobucol, with a CAS number of 216167-82-7, is a synthetic antioxidant compound that has been investigated for its potential therapeutic applications. It is a lipophilic molecule that exhibits potent antioxidant and anti-inflammatory properties, making it a candidate for the treatment of various diseases associated with oxidative stress and inflammation. Research has shown that succinobucol can effectively scavenge free radicals and inhibit the production of pro-inflammatory mediators, thereby exerting protective effects against cell damage and tissue injury. Additionally, succinobucol has been found to have potential benefits in the prevention and treatment of cardiovascular diseases, cancer, and other disorders characterized by oxidative stress and inflammation, although further studies are needed to fully elucidate its mechanisms of action and therapeutic potential. Its unique chemical structure and biological activities make succinobucol an interesting compound for ongoing research and development.
